Meprobamate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Meprobamate.
| Product ID | 62332-019_a2f676cd-53ae-4401-9553-a7d70c79bb0a |
| NDC | 62332-019 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Meprobamate |
| Generic Name | Meprobamate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-03-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090122 |
| Labeler Name | Alembic Pharmaceuticals Inc. |
| Substance Name | MEPROBAMATE |
| Active Ingredient Strength | 200 mg/1 |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2016-03-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090122 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-03-31 |
| Marketing Category | ANDA |
| Application Number | ANDA090122 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-03-31 |
| Marketing Category | ANDA |
| Application Number | ANDA090122 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-03-31 |
| Ingredient | Strength |
|---|---|
| MEPROBAMATE | 200 mg/1 |
| SPL SET ID: | 3b255bcd-0218-44f8-830b-971f5ec45276 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 46708-019 | MEPROBAMATE | MEPROBAMATE |
| 46708-020 | MEPROBAMATE | MEPROBAMATE |
| 51672-4147 | Meprobamate | Meprobamate |
| 51672-4148 | Meprobamate | Meprobamate |
| 52549-4147 | Meprobamate | Meprobamate |
| 52549-4148 | Meprobamate | Meprobamate |
| 55111-640 | Meprobamate | Meprobamate |
| 55111-641 | Meprobamate | Meprobamate |
| 62332-019 | Meprobamate | Meprobamate |
| 62332-020 | Meprobamate | Meprobamate |
| 69097-974 | Meprobamate | Meprobamate |
| 69097-975 | Meprobamate | Meprobamate |